Cargando…

In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives

BACKGROUND: Cellular reactions to alloplastic bone substitute materials (BSM) are a subject of interest in basic research. In regenerative dentistry, these bone grafting materials are routinely combined with enamel matrix derivatives (EMD) in order to additionally enhance tissue regeneration. MATERI...

Descripción completa

Detalles Bibliográficos
Autores principales: Reichert, Christoph, Al-Nawas, Bilal, Smeets, Ralf, Kasaj, Adrian, Götz, Werner, Klein, Marcus O
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780983/
https://www.ncbi.nlm.nih.gov/pubmed/19909545
http://dx.doi.org/10.1186/1746-160X-5-23
_version_ 1782174544470999040
author Reichert, Christoph
Al-Nawas, Bilal
Smeets, Ralf
Kasaj, Adrian
Götz, Werner
Klein, Marcus O
author_facet Reichert, Christoph
Al-Nawas, Bilal
Smeets, Ralf
Kasaj, Adrian
Götz, Werner
Klein, Marcus O
author_sort Reichert, Christoph
collection PubMed
description BACKGROUND: Cellular reactions to alloplastic bone substitute materials (BSM) are a subject of interest in basic research. In regenerative dentistry, these bone grafting materials are routinely combined with enamel matrix derivatives (EMD) in order to additionally enhance tissue regeneration. MATERIALS AND METHODS: The aim of this study was to evaluate the proliferative activity of human osteogenic cells after incubation over a period of seven days with commercial BSM of various origin and chemical composition. Special focus was placed on the potential additional benefit of EMD on cellular proliferation. RESULTS: Except for PerioGlas(®), osteogenic cell proliferation was significantly promoted by the investigated BSM. The application of EMD alone also resulted in significantly increased cellular proliferation. However, a combination of BSM and EMD resulted in only a moderate additional enhancement of osteogenic cell proliferation. CONCLUSION: The application of most BSM, as well as the exclusive application of EMD demonstrated a positive impact on the proliferation of human osteogenic cells in vitro. In order to increase the benefit from substrate combination (BSM + EMD), further studies on the interactions between BSM and EMD are needed.
format Text
id pubmed-2780983
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27809832009-11-24 In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives Reichert, Christoph Al-Nawas, Bilal Smeets, Ralf Kasaj, Adrian Götz, Werner Klein, Marcus O Head Face Med Research BACKGROUND: Cellular reactions to alloplastic bone substitute materials (BSM) are a subject of interest in basic research. In regenerative dentistry, these bone grafting materials are routinely combined with enamel matrix derivatives (EMD) in order to additionally enhance tissue regeneration. MATERIALS AND METHODS: The aim of this study was to evaluate the proliferative activity of human osteogenic cells after incubation over a period of seven days with commercial BSM of various origin and chemical composition. Special focus was placed on the potential additional benefit of EMD on cellular proliferation. RESULTS: Except for PerioGlas(®), osteogenic cell proliferation was significantly promoted by the investigated BSM. The application of EMD alone also resulted in significantly increased cellular proliferation. However, a combination of BSM and EMD resulted in only a moderate additional enhancement of osteogenic cell proliferation. CONCLUSION: The application of most BSM, as well as the exclusive application of EMD demonstrated a positive impact on the proliferation of human osteogenic cells in vitro. In order to increase the benefit from substrate combination (BSM + EMD), further studies on the interactions between BSM and EMD are needed. BioMed Central 2009-11-12 /pmc/articles/PMC2780983/ /pubmed/19909545 http://dx.doi.org/10.1186/1746-160X-5-23 Text en Copyright ©2009 Reichert et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Reichert, Christoph
Al-Nawas, Bilal
Smeets, Ralf
Kasaj, Adrian
Götz, Werner
Klein, Marcus O
In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives
title In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives
title_full In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives
title_fullStr In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives
title_full_unstemmed In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives
title_short In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives
title_sort in vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780983/
https://www.ncbi.nlm.nih.gov/pubmed/19909545
http://dx.doi.org/10.1186/1746-160X-5-23
work_keys_str_mv AT reichertchristoph invitroproliferationofhumanosteogeniccellsinpresenceofdifferentcommercialbonesubstitutematerialscombinedwithenamelmatrixderivatives
AT alnawasbilal invitroproliferationofhumanosteogeniccellsinpresenceofdifferentcommercialbonesubstitutematerialscombinedwithenamelmatrixderivatives
AT smeetsralf invitroproliferationofhumanosteogeniccellsinpresenceofdifferentcommercialbonesubstitutematerialscombinedwithenamelmatrixderivatives
AT kasajadrian invitroproliferationofhumanosteogeniccellsinpresenceofdifferentcommercialbonesubstitutematerialscombinedwithenamelmatrixderivatives
AT gotzwerner invitroproliferationofhumanosteogeniccellsinpresenceofdifferentcommercialbonesubstitutematerialscombinedwithenamelmatrixderivatives
AT kleinmarcuso invitroproliferationofhumanosteogeniccellsinpresenceofdifferentcommercialbonesubstitutematerialscombinedwithenamelmatrixderivatives